Three-Dimensional Imaging of Fibrinogen and Neurovascular Alterations in Alzheimer's Disease.
Three-Dimensional Imaging of Fibrinogen and Neurovascular Alterations in Alzheimer's Disease.
复制标题
阿尔茨海默病中纤维蛋白原和神经血管改变的三维成像。
DOI:
10.1007/978-1-0716-2655-9_5
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Akassoglou,Katerina
中科院分区:
文献类型:
--
作者:
Merlini,Mario;Sozmen,ElifG;Subramanian,KeshavS;Nana,AlissaL;Seeley,WilliamW;Akassoglou,Katerina
Cerebrovascular dysfunction is a hallmark of Alzheimer’s disease (AD) that is linked to cognitive decline. However, blood-brain barrier (BBB) disruption in AD is focal and requires sensitive methods to detect extravasated blood proteins and vasculature in large brain volumes. Fibrinogen, a blood coagulation factor, is deposited in AD brains at sites of BBB disruption and cerebrovascular damage. This chapter presents the methodology of fibrinogen immunolabeling-enabled three-dimensional (3D) imaging of solvent-cleared organs (iDISCO) which, when combined with immunolabeling of amyloid β (Aβ) and vasculature, enables sensitive detection of focal BBB vascular abnormalities, and reveals the spatial distribution of Aβ plaques and fibrin deposits, in large tissue volumes from cleared human brains. Overall, fibrinogen iDISCO enables the investigation of neurovascular and neuroimmune mechanisms driving neurodegeneration in disease.